The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Alcon reflected on its wholesale platform-based approach to clinical transformation during a session at the 2024 Veeva ...

After it was spun out in 2019, Alcon effectively became a ‘pure medtech company’, but one that also had a pharma portfolio ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it’s been conducting this year, bringing the total to nearly ...

improving market opportunities for global pharmaceutical wholesale and distribution players. Real-time information from drones enables logistics companies to customize their supply chain models ...